Article
SRC-3 Is Required for Prostate Cancer Cell Proliferation and Survival
1 Sept 2005
Abstract excerpt
Prostate cancer is the most common cancer in men in America. Currently, steroid receptor coactivators have been proposed to mediate the development and progression of prostate cancer, at times in a steroid-independent manner. Steroid receptor coactivator-3 (SRC-3, p/CIP, AIB1, ACTR, RAC3, and TRAM-1) is a member of the p160 family of coactivators for nuclear hormone receptors including the androgen receptor....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
